Health knowledge made personal
Join this community!
› Share page:
Search posts:

Pertuzumab Approved to Treat Some Metastatic Breast Cancers

Posted Jun 13 2012 10:10pm
The Food and Drug Administration (FDA) has approved pertuzumab (Perjeta) to treat women with HER2-positive breast cancer that has spread to other parts of the body. Pertuzumab is approved for use in combination with trastuzumab (Herceptin), another anti-HER2 therapy, and the chemotherapy drug docetaxel (Taxotere) to treat women who have not received previous anti-HER2 therapy or chemotherapy.
Post a comment
Write a comment:

Related Searches